{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:07:36Z","timestamp":1788466056650,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ejogrb.2012.11.021","type":"journal-article","created":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T23:46:19Z","timestamp":1356565579000},"page":"194-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Anti-M\u00fcllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia"],"prefix":"10.1016","volume":"167","author":[{"given":"Akira","family":"Iwase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakana","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 10","key":"10.1016\/j.ejogrb.2012.11.021_bib0005","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/cncr.26045","article-title":"Oncofertility and preservation of reproductive capacity in children and young adults","volume":"117","author":"Wallace","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-8529(05)70048-7","article-title":"Gonadal damage from chemotherapy and radiotherapy","volume":"27","author":"Howell","year":"1998","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0015","first-page":"333","article-title":"High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience","volume":"55","author":"Chauhan","year":"2010","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0020","first-page":"481","article-title":"Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia","volume":"53","author":"Garrett","year":"2008","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0025","first-page":"571","article-title":"Mullerian inhibiting substance in humans: normal levels from infancy to adulthood","volume":"81","author":"Lee","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0035","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/den487","article-title":"Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone","volume":"24","author":"Lie Fong","year":"2009","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/humrep\/dem392","article-title":"Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies","volume":"23","author":"Lie Fong","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0045","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fertnstert.2009.03.045","article-title":"Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer","volume":"94","author":"Partridge","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0050","first-page":"445","article-title":"Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report","volume":"47","author":"Kohorn","year":"2002","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","article-title":"Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study","volume":"91","author":"Badawy","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-2005-872453","article-title":"Ovarian reserve","volume":"23","author":"Macklon","year":"2005","journal-title":"Seminars in Reproductive Medicine"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0065","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.fertnstert.2010.06.010","article-title":"Serum anti-Mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve","volume":"94","author":"Iwase","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0070","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/humrep\/der006","article-title":"The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis","volume":"26","author":"Hirokawa","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2009.02.043","article-title":"Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age","volume":"94","author":"Rosendahl","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"Suppl. 1","key":"10.1016\/j.ejogrb.2012.11.021_bib0080","first-page":"S65","article-title":"The management of high-risk gestational trophoblastic tumours (GTT)","volume":"60","author":"Newlands","year":"1998","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1471-0528.2003.02419.x","article-title":"Pregnancy after EMA\/CO for gestational trophoblastic disease: a report from The Netherlands","volume":"110","author":"Lok","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0090","first-page":"1547","article-title":"Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease","volume":"82","author":"Dobson","year":"2000","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.ejogrb.2012.11.021_bib0095","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.fertnstert.2007.08.032","article-title":"Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve","volume":"90","author":"Oriol","year":"2008","journal-title":"Fertility and Sterility"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512005428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512005428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:28:38Z","timestamp":1759555718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211512005428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0301211512005428"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.11.021","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}